Kindly MD, Inc. (KDLY) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): 4.57
• Revenue Growth: -28.13%
• EPS Growth: -153.45%
• Country: US
• Employees: 23
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Equipment & Services
• EPS (TTM): -0.73
• Shares Outstanding: 6,022,148
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: 1.08
• Price to Book (P/B): 56.27
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -20.05
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: 7.66
• Enterprise Value/Gross Profit: 35.82
• Enterprise Value/Ebitda: -7.85
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 59 Neutral
• Price Target: $23.50 ▲(3.80%Upside)

The overall stock score reflects significant financial challenges, indicated by poor financial performance and valuation. However, strong technical indicators and positive corporate events due to strategic merger plans provide a counterbalance, highlighting potential growth opportunities.

Kindly MD, Inc. Business Overview & Revenue Model

Company Description

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.

How the Company Makes Money

Kindly MD, Inc. generates revenue through a combination of service fees for telemedicine consultations, subscription-based models for chronic disease management programs, and partnerships with healthcare providers and organizations. The company may also receive compensation through insurance reimbursements and direct payments from patients. Significant partnerships with technology companies and healthcare institutions contribute to its earnings by expanding its reach and enhancing the service offerings. Kindly MD's focus on personalized healthcare and technology integration allows it to differentiate its services, thereby attracting a broad client base and ensuring multiple revenue streams.

Kindly MD, Inc. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	2.47M	2.72M	3.77M	3.79M	2.50M
Gross Profit	2.39M	2.64M	3.54M	3.63M	2.42M
EBITDA	-3.78M	-3.00M	-1.36M	-2.42M	124.74K
Net Income	-4.37M	-3.62M	-1.62M	-2.54M	149.34K
Balance Sheet
Total Assets	2.56M	3.68M	1.10M	947.00K	447.64K
Cash, Cash Equivalents and Short-Term Investments	1.14M	2.27M	525.50K	186.92K	94.69K
Total Debt	666.39K	783.68K	636.38K	391.13K	109.81K
Total Liabilities	1.03M	1.11M	1.21M	565.98K	174.56K
Stockholders Equity	1.53M	2.57M	-108.41K	381.01K	273.09K
Cash Flow
Free Cash Flow	-4.29M	-3.48M	-463.91K	-457.77K	57.84K
Operating Cash Flow	-3.73M	-3.07M	-449.49K	-140.38K	121.44K
Investing Cash Flow	-563.90K	-401.63K	-14.42K	-317.39K	-63.60K
Financing Cash Flow	5.14M	5.22M	802.49K	550.00K	-45.34K

Kindly MD, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
AS	81 Outperform	$21.61B	106.02	4.38%	―	21.21%	―
AUNA	69 Neutral	$472.20M	11.17	9.93%	―	6.97%	―
BTSG	63 Neutral	$3.57B	71.29	2.30%	―	23.40%	―
KDLY	59 Neutral		―	-763.28%	―	-28.13%	-153.45%
Sector *	56 Neutral	$5.79B	21.50	-28.61%	5.76%	10.78%	-34.04%
CORZ	45 Neutral	$4.18B	―	160.33%	―	-26.76%	-1883.89%
BKHA	―		34.74	4.05%	―	―	―

Kindly MD, Inc. Corporate Events

Kindly MD Changes Ticker Symbols Amid Merger

On May 23, 2025, Kindly MD, Inc. announced a change in its Nasdaq ticker symbols from ‘KDLY’ to ‘NAKA’ for its common stock and from ‘KDLYW’ to ‘NAKAW’ for its tradable warrants, reflecting its strategic alignment with Bitcoin-focused growth plans through a proposed merger with Nakamoto Holdings Inc. This change, effective immediately, signifies KindlyMD’s new vision to adopt a Bitcoin treasury strategy, enhancing innovation and growth opportunities. The merger has been approved by the company’s majority shareholders and the Utah Department of Commerce, allowing KindlyMD to conduct business under the Nakamoto name. The company’s securities will continue to be listed on Nasdaq under the new symbols, with no changes to its capital structure or shareholder rights.

KindlyMD Partners with Anchorage for Bitcoin Strategy

On May 21, 2025, KindlyMD Inc. and Nakamoto Holdings announced a strategic partnership with Anchorage Digital, a federally chartered digital asset bank, to provide exclusive custody and trading services for KindlyMD’s Bitcoin treasury operations. This partnership, following a merger agreement between KindlyMD and Nakamoto, aims to advance corporate Bitcoin adoption by establishing a Bitcoin treasury strategy. The collaboration is backed by $710 million in financing, marking the largest PIPE for a public crypto-related transaction, and is expected to position Bitcoin at the center of corporate strategy, enhancing value for shareholders and stakeholders.

KindlyMD Announces Merger with Nakamoto Holdings

On May 18, 2025, KindlyMD, Inc. announced that its majority shareholders approved a merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company. The merger, expected to close in the third quarter of 2025, aims to integrate Bitcoin into KindlyMD’s operations, potentially enhancing its market position and providing long-term value for investors. This strategic move reflects a shared vision of incorporating Bitcoin as a core asset, with the merger set to bring significant changes to KindlyMD’s capital structure and governance.

Kindly MD, Inc. Updates Executive Employment Agreements

On May 12, 2025, Kindly MD, Inc. made significant changes to the executive employment agreements of its top executives, including CEO Tim Pickett, CFO Jared Barrera, and COO Adam Cox. These changes involved modifications to stock options, vesting schedules, and a waiver of rights to future equity in the company and its affiliates. Additionally, independent directors received adjusted stock options and restricted stock, with all options priced based on the prior day’s closing stock price. Following these changes, the company has issued 730,923 shares of common stock through warrant exercises, generating $4,219,584.33 by May 15, 2025.

KindlyMD Announces Merger with Nakamoto Holdings

On May 12, 2025, KindlyMD, Inc. announced a merger agreement with Nakamoto Holdings Inc., a Bitcoin-native holding company, to establish a Bitcoin treasury strategy. This merger aims to position the combined entity as a leading public market Bitcoin treasury, leveraging Nakamoto’s expertise in Bitcoin strategy and KindlyMD’s healthcare operations. The merger, supported by a $510 million PIPE financing and $200 million in convertible notes, reflects a strategic move to integrate Bitcoin into global capital markets. The transaction, which requires shareholder approval, is expected to bring long-term value to shareholders by combining healthcare services with Bitcoin treasury management.